Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil · Delayed Price · Currency is BRL 113.50
0.00 (0.00%)
Dec 23, 2025, 10:43 AM EST
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 292.24 billion as of December 24, 2025. Its market cap has increased by 45.90% in one year.
Market Cap
292.24B
Enterprise Value
292.51B
Revenue
17.11B
Ranking
n/a
PE Ratio
1,258.71
Stock Price
113.50
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 361.82M to 292.24B, an increase of 80,670.65%. That is a compound annual growth rate of 36.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 292.01B | 55.56% |
| Dec 31, 2024 | 187.71B | 61.05% |
| Dec 29, 2023 | 116.56B | -24.59% |
| Dec 30, 2022 | 154.57B | 36.78% |
| Dec 31, 2021 | 113.01B | 44.11% |
| Dec 31, 2020 | 78.42B | 51.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 91.45B |
| Raia Drogasil | 39.57B |
| Hypera | 14.48B |
| Fleury | 7.92B |
| Odontoprev | 5.95B |
| Diagnósticos da América | 5.24B |
| Empreendimentos Pague Menos | 4.16B |
| Oncoclínicas do Brasil Serviços Médicos | 3.05B |